The All of Us Researchers Convention provides an opportunity for a broad spectrum of researchers using the All of Us Research Program data and tools offered through the Research Hub to showcase their work with colleagues, peers, and others who share a passion for advancing health research. The two-day virtual event will focus on researchers at various educational and professional career stages across two separate but linked events: the Minority Student Research Symposium (March 31) and Science Day (April 1).
The All of Us Research Program would not be possible without the partnership of its participants. Thank you for your support and continued engagement with the program.
The All of Us Minority Student Research Symposium (MSRS) elevates the work of student researchers from underrepresented communities by engaging minority students and faculty/mentors through use of the Data Browser to research, design, and display a poster presentation on their findings.
Multiple touchpoints, including a professional development series, will help cultivate a mentor/student network.
MSRS will begin at 10am and end at 6pm ET.
The All of Us Science Day is an event that seeks to bring the All of Us data to life. Researchers, who are currently registered users of the All of Us Researcher Workbench and have created an active workspace on the platform, are invited to submit proposals on their research projects using the All of Us data. After a review process, selected researchers will participate in a series of panel discussions on their research and how it aligns to the goals and values of the All of Us Research Program.
Science Day will begin at 10am and end at 4:15pm ET.
The All of Us Research Program is a historic effort by the National Institutes of Health (NIH) to create one of the largest most diverse biomedical databases by collecting and studying data from at least one million people living in the United States. The database will help transform the future of health research by equipping researchers nationwide with expansive health data from diverse populations, especially those underrepresented in biomedical research. The dataset combines biological factors and social determinants on a large, inclusive scale.
Unlike research studies that focus on one disease or a specific group of people, the program is building a database that can inform thousands of studies on a variety of health conditions, improve understanding of health and disease, identify opportunities to reduce disparities, and enable more precise approaches to care. The initiative is guided by core values such as transparency, diversity, and keeping participant information secure. It will equip researchers to make discoveries that can enable more precise approaches to care.
Learn more about the All of Us Research Hub
Visit Booth 12 to cast your votes for your favorite projects to determine our People’s Choice winners.
Visit the Lobby to hear a pre-recorded welcome message from All of Us Chief Engagement Officer, Dr. Karriem Watson.
Diet and Hypertension in Black Americans
Prevalence of Type 2 Diabetes within Asian immigrant and U.S.-born Asian populations
The Impact of the Microbiome on Crohn's Disease
Impact of Nutrition and Cardiovascular Disease Among African American Weight Management Program Participants
Comparing the patient profile for diabetes and co-occurring chronic kidney disease in black vs. white patients using the All of Us data
Exploring the Impact of Experience of Discrimination on People's Physical Activity Level and the Effects of Couple Relationship Status
Sickle Cell Disease
Atopic Dermatitis and its Psychosocial Illness
Solid Organ Transplants
A conversation to showcase the power of mentorship and the personal and professional growth that make these connections so meaningful for all involved.
Welcome & Introductions:
Program Lead, Black Greek Letter ConsortiumAll of Us Research Program
Jennifer M. Jones is the Executive Director of Student Development at Southern Methodist University where she has been employed for the over 30 years, 16 of those years in various positions within Residence Life and Student Housing. She also served as the SMU NPHC advisor for eight years. She is presently the Immediate Past-President of the National Pan-Hellenic Council and has also served as the past National First Vice President of the National Pan-Hellenic Council and Regional Secretary for the Southwestern Region of NPHC.
In various capacities, Ms. Jones has given workshops and spoken on college campuses across the country from diversity and inclusion workshops to being the keynote speaker at national conventions and conferences. She has been a consultant for a number of universities and participates as an assessor with the Fraternity & Sorority Coalition Project. She has served as a Cluster Facilitator and Lead Facilitator for the LEADERSHAPE Institute for over 15 years and now serves on the LeaderShape Board of Directors. She was Chair of the Communications Committee of the NASPA Knowledge Community and served as the Co-Chair for the NASPA Fraternity and Sorority Knowledge community. She was one of the first to serve as a Board of Trustee on the Circle of Sisterhood Foundation whose mission is to leverage the collective influence of sorority women to raise financial resources for entities around the world that are removing educational barriers for girls and women facing poverty and oppression. She has served as an Interfraternal Institute (IFI) Fellow three times and has also been a workshop facilitator for the institute. She is a member of several professional organizations. She is a member of the Association of Fraternity and Sorority Advisors, and served on a number of committees, Regional Director, and the VP of Membership for the Association. She is the Program Lead for the Black Greek Letter Consortium in partnership with the All of Us Research Program.
Ms. Jennifer M. Jones received her BA in Sociology and a Master of Liberal Arts from Southern Methodist University. She is an author, a wife, a mother, and a grandmother.
Chief Engagement Officer, All of Us Research Program
Karriem Watson, D.H.Sc., M.S., M.P.H., is the Chief Engagement Officer of the All of Us Research Program at the National Institutes of Health. In this role, he will lead the Division of Engagement and Outreach, overseeing the program’s efforts to foster relationships with participants, community partners, researchers, and providers across the United States. His focus will be on engaging people and populations who have been left out of medical research in the past and inviting them to help drive new biomedical discoveries.
Karriem comes to All of Us from his role as associate executive director of the Mile Square Health Center, a group of Federally Qualified Health Centers in Chicago affiliated with the University of Illinois Hospital and Health Sciences System. He also served as the associate director of community outreach and engagement for the University of Illinois Cancer Center and as a research assistant professor in the University of Illinois Chicago (UIC) School of Public Health. Beyond his work with UIC, he has served as co-lead of the All of Us Engagement Core at the Meharry-Vanderbilt Alliance, cultivating positive relationships with the program’s participant ambassadors.
Karriem holds a Doctorate in Health Science (Global Health), a Master of Science in Basic Medical Research, and a Master’s in Public Health (Community Health Sciences). He has served as a principal investigator on multiple projects including those funded by the National Cancer Institute, the National Institute on Minority Health and Health Disparities, and the All of Us Research Program. His expertise in community-academic partnerships is also supported in his role as board chair of the Community Campus Partnerships for Health. His contributions have earned him recognition by the Chicago Urban League, American Heart Association, LUNGevity Foundation, and others.
Director and Lipman Chair in Oncology, VCU Massey Cancer Center
Senior Associate Dean for Cancer Innovation
Professor of Pulmonary Disease and Critical Care Medicine, VCU School of Medicine
As director of VCU Massey Cancer Center, Robert Winn, M.D., oversees a cancer center designated by the National Cancer Institute that provides advanced cancer care, conducts groundbreaking research to discover new therapies for cancer, offers high-quality education and training, and engages with the community to make advancements in cancer treatment and prevention equally available to all. He is leading the nation in establishing a 21st-century model of equity for cancer science and care, in which the community is informing and partnering with Massey on its research to best address the cancer burden and disparities of those the cancer center serves, with a local focus but global impact.
In addition to directing the activities of Massey’s 250-plus research members – scientists and physicians from 39 departments in nine colleges and schools at VCU – he also manages a research laboratory at VCU. His current basic science research, which has been supported by multiple National Institutes of Health and Veterans Affairs Merit awards, focuses on the molecular mechanisms and novel therapeutic approaches for human models of lung cancer. He has authored or co-authored more than 60 published manuscripts in peer-reviewed academic journals.
Also a pulmonologist, Winn is committed to community-engaged research centered on eliminating health disparities. He is a principal investigator on several community-based projects funded by the NIH and National Cancer Institute, including the All of Us Research Program, a NIH precision medicine initiative. He has received national and international acclaim for his efforts to empower underserved patient populations, improve health care delivery and ensure equal access to cancer care.
Winn’s previous faculty appointments include serving as director of the University of Illinois Cancer Center from 2015 to 2019 and as associate vice chancellor of health affairs for community-based practice at the University of Illinois Hospital and Health Science System from 2013 to 2019. Prior to joining UIC, he spent 13 years at the University of Colorado Health Sciences Center and School of Medicine in a variety of leadership roles and clinical faculty appointments, including associate dean of admissions and vice chair of career development/diversity inclusion. Moreover, Winn has nearly 20 years’ commitment to Veterans Affairs health services and held appointments at the Denver VA and Jesse Brown VA in Chicago, where he established the first multidisciplinary pulmonary nodule clinic.
The recipient of numerous awards and honors, Winn was awarded the National Cancer Institute Center to Reduce Cancer Health Disparities CURE Program Lifetime Achievement Award. He is a member of the National Cancer Policy Forum of the National Academies of Sciences, Engineering, and Medicine and of several other professional societies.
Winn holds a B.A. from the University of Notre Dame and an M.D. from the University of Michigan Medical School in Ann Arbor. He completed an internship and residency in internal medicine at Rush-Presbyterian-St. Luke’s Medical Center in Chicago and a fellowship in pulmonary and critical care medicine at the University of Colorado Health Sciences Center in Denver.
Data and Quality Manager, South Suburban HIV/AIDS Regional Clinics
Alexander Kimbrough currently serves as the Data and Quality Manager at the South Suburban HIV/AIDS Regional Clinics (SSHARC) in south suburban Chicago. He received his Bachelor’s in Biological Sciences and his Master’s in Public Health with a concentration in Epidemiology from the University of Illinois Chicago in 2015 and 2019, respectively. His academic research background includes topics such as HIV, cancer, and health disparities. Post graduate school, he has also been contracted on projects as a social epidemiologist. Alexander has a passion for epidemiological research of communicable diseases, and he hopes to begin his studies for his terminal degree this fall.
COPE Survey and Substance Usage
Impact of Physical Activity on Depression and Anxiety during COVID era and Disparities by Race
The Impact of the COVID-19 Pandemic: Food Insecurity
Disparities in the Impact of COVID-19
Teen Pregnancy and Mental Health
If Depression and Anxiety has Increased Over Time within the LGBTQ+ Community
How Representative is the All of Us Data Browser on Mental Disorders
Genetic Testing for Psychiatric Disorders
Ethnic Minorities and the Risk of CVD
Racial and Ethnic Minorities Have Different Healthcare Perceptions Than Non-Hispanic Whites in America
A Literature Review of the All of Us Research Program and Preliminary Results of the “Structural Heart Disease Risk in the Hispanic/Latino Community
Common dermatological conditions in skin of color: analysis from the All of Us Research Program
Access to Healthcare for Genderqueer People
Minimizing Drug Overdose & Unintentional Deaths in Minority Adolescents
Polycystic Ovarian Syndrome
Prevalence of Iron Deficiency in Women
The Impact Sickle Cell Disease has on Pregnancy
How Endometriosis Compares Across Various Demographics
Mental Health on Reproductive Health
Trained Genetic Epidemiologist
Vice President of Genetics and Precision Immunology at Alumis Inc.
Mera is an NIH/NHGRI-trained genetic epidemiologist and human geneticist. She leads Alumis’s efforts to leverage genomics and genetics to guide research and development of novel and precise autoimmune disease therapeutics. Prior to Alumis, Mera lead genomics-based company ideation for Alumis out of Foresite Labs, a VC-backed company incubator. Mera previously did a stint in the start-up world leading the Precision Medicine and Translational Genetics group at Goldfinch Bio. Prior to Goldfinch, she spent six years at Pfizer in roles across drug discovery, development, and medical affairs. Prior to Pfizer, she was at the National Human Genome Research Institute, where she developed new methods for analyzing rare variants in DNA sequence data to discover novel genetic causes of coronary artery disease. During her early career she trained in a variety of fields, including molecular biology, bioinformatics, and science policy.
Janssen Pharmaceutical Companies of Johnson & Johnson
Shelina Ramnarine PhD is a Product Director Cardiovascular Payer Marketing at Janssen Pharmaceuticals. Shelina is a recognized change catalyst with proven capabilities to take innovative ideas from concept to execution. She is a collaborator with an aptitude to connect people and ideas. She has experience collaborating with technical, scientific, and commercial colleagues to drive and deliver strategic initiatives. Shelina holds a PhD in Human and Statistical Genetics from Washington University in St Louis and earned undergraduate degrees in Biology and Statistics from the University of Georgia.
Center for Disease Control and Prevention in the Office of Genomics and Precision Health
Danielle Rasooly is a scientist specialized in applying methods in machine learning and causal inference to large-scale medical and genetic data to understand genetic determinants of disease and to inform clinical decision-making. Her current area of interest lies at the intersection of data science, genetics, epidemiology, and public health, involving high-throughput analysis and modeling to understand the underlying biological, genetic, and environmental mechanisms that lead to cardiometabolic diseases. Dr. Rasooly received her Bachelor of Science degree in Mathematics from Stanford University and her Ph.D. in Bioinformatics and Integrative Genomics from Harvard University, where she also completed her post-doctoral training in machine learning, artificial intelligence, and biomedical data science.
Stop by and meet with NIH Research Scholars to learn more about their poster presentations. Don’t forget to cast your vote in Booth 12!
Tune in to hear the winners of this year's MSRS, the People’s Choice winner, and learn more about the future of the Minority Student Research Symposium.
Assistant Professor, Department of Community Medicine and Population Health
Engagement Lead UA HPO
University of Alabama
Dr. Lilanta Joy Bradley is an Assistant Professor in the Department of Community Medicine and Population Health at the University of Alabama (UA) where she also serves as the Practicum Director for the master’s program. This Atlanta, GA native completed her doctorate in Health Promotion and Behavior from the University of Georgia in 2017. She represents UA’s All of Us Research Program team as the Community Engagement Lead to educate and promote awareness on the importance of participating in biomedical research, especially in historically underrepresented populations. Dr. Bradley has a Health Disparities Research Education Certificate from UAB as a 2019-2020 RCMAR Scientist. Dr. Bradley’s most recent achievement is joining the sixth cohort of RWJF’s Interdisciplinary Research Leaders where her team is addressing structural racism, living in rural communities, and early childhood obesity. The overarching goal of her career is investigating and improving sexual and reproductive health for communities of color.
Scientific Product and Portfolio Manager
Vanderbilt University Medical Center
All of Us Data and Research Center
All of Us Science Day Advisory Committee Co-Chair
Kelsey Mayo, PhD, is a Scientific Product and Portfolio Manager at Vanderbilt University Medical Center. Dr. Mayo is a multidisciplinary scientist with over 10 years of precision medicine research experience and a founding member of the All of Us Data and Research Center. Dr. Mayo recently led the successful development and launch of the Researcher Workbench, the All of Us Research Program’s cloud-based analysis platform. She began her career as a Beckman Scholar at the Georgia Institute of Technology and later earned her doctorate designing advanced therapeutics as an NSF Graduate Research Fellow at Vanderbilt University. In her current role, Dr. Mayo is dedicated to partnering with the scientific community and finding creative solutions which accelerate biomedical research innovation and translation.
Social support as a protective factor for depression during the COVID-19 pandemic: What types and for whom?
Dr. Karmel Choi is a clinical psychologist and assistant professor at Harvard Medical School/Massachusetts General Hospital whose research focuses on genetic, epidemiological, and translational methods to characterize psychiatric resilience and inform the prevention of common stress-related disorders (e.g., depression and PTSD) across the life course. Dr. Choi directs the Precision Prevention Program in the MGH Center for Precision Psychiatry.
The impact of visual impairment on social isolation and anxiety during the COVID-19 pandemic
Dr. Zebardast is a clinician scientist and full-time member of the Glaucoma Service at Mass Eye and Ear. She specializes in the treatment of adult glaucoma and combined glaucoma and cataracts, with a particular interest in minimally invasive glaucoma surgeries (MIGS).
She has received numerous awards and honors for her academic and research accomplishments and has published in top ophthalmology journals. She has made significant contributions to global epidemiologic research having established the Indian Family Angle Closure Evaluation with colleagues at Aravind Eye Institute in Southern India. Among other findings, this study determined that siblings of individuals with known angle closure have a greater than 1 in 3 risk of developing the condition. Additionally, she has worked with a many large datasets to understand the prevalence of eye disease and its impact.
Dr. Zebardast’s current research focuses on developing precision medicine-based tools for disease detection, aiding clinicians in assessing for disease progression and eventually optimizing patient-related outcomes. She collaborates widely with experts from MGH and Ocular genomics institute to define image-based and longitudinal endophenotypes for glaucoma using machine learning methods and to understand the genetic underpinning of vision loss in this blinding disease. This work could lay the foundation for precision medicine approaches to screening and diagnosis that combines clinical phenotypes and genetic background to improve assessment of disease risk for any individual.
Dr Zebardast was selected for the NIH/NEI-funded K12 Harvard-Vision Clinical Scientist Training Program as well as the Gliklich Innovation Scholarship program in 2019. She is currently funded by an NIH K23 career development award, an NIH R21 award as well as the Research to Prevent Blindness Career development award.
Effect of everyday discrimination on depression and suicidal ideation during the COVID-19 pandemic: a large-scale, repeated-measures study in the All of Us Research Program
Dr. Lee received her bachelor’s degree in psychology from New York University and Ph.D. in epidemiology from Brown University. Her doctoral dissertation included the discovery that prenatal immune activation due to maternal bacterial infection is a risk factor for schizophrenia and related psychosis. During her postdoctoral training, Dr. Lee has expanded her skill sets in statistical genetics to examine genetic risk factors for psychiatric disorders and their interplay with environmental risk factors. With her unique combination of skills in causal inference, epidemiology, statistical genetics, Dr. Lee has played a crucial role in ongoing national and international collaborative consortia. This has included analyses through the PsycheMERGE consortium that used large-scale health systems and genomic data across multiple biobanks.
In addition, Dr. Lee has leveraged her doctoral training in causal inference to investigate selection bias in biobank-based genomic analyses, which are typically conducted in volunteer samples that may not represent the underlying population of interest. In recent work, presented at the 2021 World Congress of Psychiatric Genetics, she has demonstrated that selection bias can lead to biased estimates of genetic risk and provided a framework for addressing this problem. Lastly, Dr. Lee has long been interested in health inequities among racial and ethnic minority populations. Supported by the International HundredK+ Cohort Consortium, she has recently conducted an analysis examining the risk and protective factors of adverse mental health outcomes during the COVID-19 pandemic in diverse populations using data from the All of Us Research Program.
Pharmacogenomic medication exposures within All of Us Research Program Participants
Racial and Ethnic Disparities in Cost-related Barriers to Medication Adherence in a Nationwide Cohort
Arash Delavar is a 4th year medical student at UC San Diego currently on a research year. Arash received his MPH from Washington University in St. Louis with an emphasis in epidemiology and biostatistics, and has research interests in social determinates of health, cancer epidemiology, health policy, and ophthalmology. He plans to enter the field of ophthalmology and hopes to become an academic physician in his career.
Predicting adverse drug events using the All of Us cohort data: A feasibility study
Dr. Christine Cadiz is one of the founding faculty members in the Department of Clinical Pharmacy Practice at the UCI School of Pharmacy and Pharmaceutical Sciences. She received her PharmD from UCSD Skaggs School of Pharmacy & Pharmaceutical Sciences and completed a PGY-1 pharmacy practice residency at UCSF Medical Center. She currently practices as a clinical pharmacist working with a multidisciplinary cardiology team to care for patients with advanced heart failure and patients with ventricular assist devices (VAD). Her research areas of interest are in cardiology, pharmacogenomics, medication use, and health disparities. She has a passion for teaching and precepting, as well as introducing young kids to STEM. In her spare time, Christine loves to go camping with her husband and two boys, surf, hike, eat, travel, or just snuggle up on the couch to watch movies.
Division Chief for Ophthalmology Informatics and Data Science
Shiley Eye Institute
UC San Diego Health
Sally L. Baxter, MD, MSc is an Assistant Professor of Ophthalmology and Biomedical Informatics at the University of California San Diego. She is a physician and informaticist integrating comprehensive ophthalmic care with research investigation in big data, artificial intelligence, and health information technology systems. She is double board-certified in both ophthalmology and clinical informatics.
Dr. Baxter was an Angier B. Duke Scholar at Duke University, where she graduated summa cum laude with degrees in Biology, Physics, and Genome Science & Policy. She was one of 40 American students awarded the prestigious United States Marshall Scholarship, which funded her Master of Science (MSc) in Public Health at the London School of Hygiene & Tropical Medicine (University of London), one of the world's leading institutions for research and education in public and global health. She then completed her M.D. at the Perelman School of Medicine at the University of Pennsylvania with a full academic scholarship through the 21st Century Scholars Program. She returned to her hometown of San Diego to complete her internship in internal medicine, residency in ophthalmology, and fellowship training in biomedical informatics, all at UCSD.
Dr. Baxter is dedicated to providing the highest level of patient care. She was awarded the Charles A. Oliver Memorial Prize for the highest record of performance in ophthalmology at Penn and the Lamont Ericson, MD Award for outstanding patient care by a resident at UCSD. Her surgical skills are informed by decades of experience developing technical physical capabilities as a classically trained pianist and violinist and as a former NCAA Division I pole vaulter, achieving All-Time Top 5 record performance while at Duke.
Dr. Baxter's research interests involve using data from electronic health records and imaging tests to enhance clinical outcomes using traditional statistical methods as well as machine learning and artificial intelligence. She is innovating ways of incorporating digital health technology into patient care. She is also passionate about education, having served as Chief Resident at the Shiley Eye Institute and being involved in education and training of undergraduate students, graduate students, medical students, residents, and fellows.
Professor of Medicine and Public Health Sciences
Chief, Division of General Internal Medicine
Co-Director, Miami Clinical & Translational Science Institute
University of Miami Health System
Dr. Carrasquillo is a Professor of Medicine and Public Health Sciences and Associate Dean for Clinical and Translational Research at the University of Miami’s Miller School of Medicine. He is a Puerto Rican born physician who was raised in the Bronx. He graduated summa cum laude from the Sophie Davis School of Bio-Medical Education at City College, and obtained his MD degree from the New York University School of Medicine. He completed a three-year internal medicine residency at Columbia-Presbyterian Medical Center, Harvard’s two-year General Medicine Fellowship and an MPH from the Harvard School of Public Health. For eight years, he was Director of the Center of Excellence in Health Disparities Research at Columbia University.
For thirteen years he served as Chief of the Division of General Internal Medicine at the University of Miami where he led a clinical, teaching and research enterprise of 51 full time faculty. Dr. Carrasquillo now serves as co-Director of the University’s Clinical and Translational Science Institute whose mission is to drive research translation into evidence-based clinical and community practices to improve the health of South Florida’s diverse population. He is a national expert in minority health, health disparities, community based participatory research, access to care and community health worker interventions. He has over twenty years of experience leading large NIH Center grants and randomized trials, totaling over $60 million in funding. His work includes research in diabetes, cardio-vascular disease, HIV, cancer and most recently in precision medicine. His research has been published in many of the nation’s top medical journals and he servers on numerous NIH grant review committees. He is also active in various national organizations, including numerous current and past leadership roles in the Society of General Internal Medicine, Physicians for a National Health Program, National Hispanic Medical Association and Latinos for Health Equity. In Miami, he is a Board Member of the Miami-Dade Area Health Education Center and the South Florida Health Council. He is often called upon by the media to discuss his research as well as health care topics of particular relevance to the Hispanic community including being a frequent guest on most of the major Latino television networks.
Since the COVID pandemic began, his work has shifted to focus mostly on COVID. He helped lead the health systems institutional response to COVID team and took a lead role in community education around COVID including numerous media appearances and presentations to community groups. He also leading the NIH sponsored Florida Community-Engaged Research Alliance Against COVID-19 in Disproportionately Affected Communities (FL-CEAL). Other COVID research he has led/lead includes the Healthcare Worker Exposure Response and Outcomes study (HERO), a phase 3 clinical trial to determine the safety and efficacy COVID vaccine (J&J ENSEMBLE trial), and a PCORI funded initiative to train Community Health Workers in COVID research.
A special fireside conversation between participants and researchers to discuss the impact participation in research makes. This first of its kind session will pair an All of Us participant ambassador with program researchers for a conversation on the importance of diversity in research (from the participant and researcher perspectives), what it means to be included, and how All of Us and the Researcher Workbench are important tools in driving medical research and precision medicine forward.
Cardiovascular Health Disparities in Racial and Other Underrepresented Groups: Initial Results From the All of Us Research Program
Julian is a Neurologist currently working as a Postdoctoral Research Fellow. He received his MD magna cum laude from the National University of the Northeast (Argentina) and completed his clinical training at FLENI (Buenos Aires, Argentina). His research interests include the use of clinical data, genomics, radiomics and novel modeling tools like machine learning to better understand the underlying biology of stroke and cardiovascular disease.
Biological Age Influences Clinically-Evident and Asymptomatic Cerebrovascular Disease: Combined Analysis in the UK Biobank and All of Us
Cyprien Rivier MD, MSc is a Postdoctoral Research Fellow at the Falcone Lab in the Department of Neurology, Yale University. He completed his MD and a Masters in Mathematics at the University of Geneva and then emigrated to the United States to pursue advanced research training in population genetics, genomic medicine and data sciences. Dr. Rivier’s work focused on understanding how common and rare genetic variations influences brain health, cerebrovascular diseases and other aging-related traits and conditions, including cognitive decline, dementia and frailty. Important areas of emphasis within this portfolio include the utilization of multiple different data layers (neuroimaging, EHR and other omics technologies) and the study of health disparities in population genetics and genomic medicine.
Association between Atopic Dermatitis and COVID-19 infection: A Case-Control Study
Ryan Fan is a current fourth-year medical student at the Yale School of Medicine. He is completing a one-year research fellowship under the mentorship of Dr. Jeffrey M. Cohen, Assistant Professor of Dermatology at the Yale School of Medicine, and is currently studying the epidemiologic associations of various inflammatory skin disorders with comorbid diseases. Prior to medical school, Ryan graduated summa cum laude from the University of Pennsylvania in 2018 with a Bachelor of Arts in biological basis of behavior. As an undergraduate, he conducted translational oncology research at the Perelman School of Medicine at the University of Pennsylvania and cancer immunology research at Harvard Medical School. Ryan will be applying for dermatology residency later this year and aspires to pursue a career as an academic dermatologist.
Sexual orientation disparities in subjective well-being during COVID-19: The roles of alcohol use, depressive symptoms, and everyday life discrimination
Jeremy Luk is a clinical psychologist at the Office of the Clinical Director of the National Institute on Alcohol Abuse and Alcoholism. He obtained his Ph.D. in clinical psychology from the University of Washington and received postdoctoral training at the Eunice Kennedy Shriver National Institute of Child Health and Human Development. His research is focused on alcohol use and misuse, mental health issues, suicide prevention, and health disparities.
Racial-Ethnic Disparities in Continuous Glucose Monitoring Use Among Adults with Type 2 Diabetes
Dr. Feifan Liu is an assistant professor of Department of Population and Quantitative Health Sciences and Department of Radiology at University of Massachusetts Chan Medical School. He is trained in computer science with expertise in natural language processing, machine learning and deep learning. Dr. Liu has extensive experience in exploiting advanced AI techniques models to analyze heterogeneous and complex healthcare data for information extraction, predictive modeling, preventative data analytics. His research recently focuses on AI model interpretability, generalizability, and AI fairness to advance health equity.
Achieving a representative sample of Asian Americans in biomedical research through community based approaches
Ms. Fornessa Randal is the Co-Director of the University of Chicago’s Center for Asian Health Equity (CAHE) and Executive Director for the Asian Health Coalition, a community-based organization affiliated with the University of Chicago. Ms. Randal has over 20 years of experience in health systems innovation, as well as minority and community health planning and implementation. Her background extends to cancer disparities research, public health, outreach, research engagement and executive leadership. She is recognized both locally and nationally for her innovative approach to program design and implementation.
Fornessa has disseminated and transformed local health initiatives into statewide and national models and developed prototypes, which have been recognized by both the National Institutes of Health (NIH) and Centers for Disease Control and Prevention. She is the Principal Investigator for several federally funded programs, including the NIH’s All of Us Research Program and leads for the Asian Engagement and Recruitment Core; Hepatitis B Outreach, Awareness, and Education to Immigrants; and the Office of Minority Health-funded All One Community or A1C program guiding reduction of a1c in targeted communities.
Fornessa has authored and co-authored peer-reviewed articles, enjoys Marvel movies, as well as spending time with family and friends!
MPH and Interdisciplinary Pathobiology PhD Student, Tuskegee University
MSRS 2022 Advisory Board Member
Atiya Shahid M.S, is a MPH and Interdisciplinary Pathobiology PhD dual-degree student emphasizing in Epidemiology and Risk Analysis at Tuskegee University. She is a proud native of Saint Louis, MO. She obtained her bachelor’s degree in public health from Xavier University of Louisiana and her first master’s from Tuskegee University. Her current research is examining the correlations between Cervical Cancer, HIV, and HPV in African American women living in the Blackbelt region. Atiya hopes that her research and experience will help her assist in decreasing systemic inequalities and disparities as well as aid in advocation efforts for people of color and other minority communities.
She currently serves as the Student Representative for the All of Us Minority Student Research Symposium Advisory Board, President of the Graduate Public Health Department, Student Recruiter for the Tuskegee University Department of Graduate Public Health’s Recruitment Committee, member of Black Ladies in Public Health, and founder of ElleMi LLC.
Chief Operating Officer
All of Us Research Program
Stephanie Devaney, Ph.D., is the Chief Operating Officer of the All of Us Research Program at the National Institutes of Health. In this role she is responsible for overseeing the operations of the All of Us Research Program to ensure the program fulfills its mission of advancing precision medicine research. Prior to this she led the coordination of the Precision Medicine Initiative (PMI) from the Office of the Chief of Staff at the White House. In this role she coordinated the many components of the Initiative and guided the vision of the overall effort, along with the many federal partners. Before joining the White House, Stephanie worked in the Office of the Director at the National Institutes of Health. There she helped advance policies critical to biomedical research and the NIH mission and assisted in the development of programs and research initiatives to advance national scientific priorities. Stephanie received her Ph.D. in molecular genetics from the George Washington University and her B.S. in biology from The Ohio State University.
Core Faculty, Berman Institute of Bioethics
Assistant Professor, Department of Health Policy and Management
Johns Hopkins Bloomberg School of Public Health
Kadija Ferryman, Ph.D., is a cultural anthropologist who studies the social, cultural, and ethical implications of health information technologies. Specifically, her research examines how genomics, digital medical records, artificial intelligence mediate the production of social difference and racial disparities in health. She is currently Assistant Professor at the Johns Hopkins Berman Institute of Bioethics and the Department of Health Policy and Management at the Bloomberg School of Public Health at Johns Hopkins University. She completed postdoctoral training at the Data & Society Research Institute in New York, where she led the Fairness in Precision Medicine research study, which examined the potential for bias and discrimination in predictive precision medicine.
She earned a B.A. in Anthropology from Yale University, and a Ph.D. in Anthropology from The New School for Social Research. Before completing her Ph.D., she was a policy researcher at the Urban Institute where she studied how housing and neighborhoods impact well-being, specifically the effects of public housing redevelopment on children, families, and older adults. Dr. Ferryman is a member of the Institutional Review Board for the All of Research Program, a Mozilla Open Science Fellow, and an Affiliate at the Center for Critical Race and Digital Studies. She has published research in journals such as Journal of the American Medical Informatics Association, Paediatric and Perinatal Epidemiology, the Journal of Health Care for the Poor and Underserved, European Journal of Human Genetics, and Genetics in Medicine. Dr. Ferryman’s research has been featured in multiple publications including Nature, STAT, and The Financial Times.